Risk assessment and prediction of occult uterine sarcoma in patients with presumed uterine fibroids before high-intensity focused ultrasound treatment

References

• Consensus for diagnosis and treatment of uterine myoma. Zhonghua Fu Chan Ke Za Zhi. 2017;52(12):793–800. doi: 10.3760/cma.j.issn.0529-567x.2017.12.001.
   PubMedGoogle Scholar
• Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107. doi: 10.1067/mob.2003.99.
   PubMed Web of Science ®Google Scholar
• Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3–9. doi: 10.1002/ijgo.13102.
   PubMed Web of Science ®Google Scholar
• Flynn M, Jamison M, Datta S, et al. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195(4):955–964. doi: 10.1016/j.ajog.2006.02.020.
   PubMed Web of Science ®Google Scholar
• Chen BP, Clymer JW, Turner AP, et al. Global hospital and operative costs associated with various ventral cavity procedures: a comprehensive literature review and analysis across regions[J]. J Med Econ. 2019;22(11):1210–1220. doi: 10.1080/13696998.2019.1661680.
   PubMed Web of Science ®Google Scholar
• Song T, Kim TJ, Lee SH, et al. Laparoendoscopic single-site myomectomy compared with conventional laparoscopic myomectomy: a multicenter, randomized, controlled trial. Fertil Steril. 2015;104(5):1325–1331. doi: 10.1016/j.fertnstert.2015.07.1137.
   PubMed Web of Science ®Google Scholar
• Wu PC, Sheu BC, Huang KJ, et al. Laparoendoscopic two-site myomectomy (LETS-M) using conventional laparoscopic instruments and the glove-port technique. J Formos Med Assoc. 2022;121(11):2248–2256. doi: 10.1016/j.jfma.2022.04.013.
   PubMedGoogle Scholar
• Munro MG. Hysteroscopic myomectomy of FIGO type 2 leiomyomas under local anesthesia: bipolar radiofrequency needle-based release followed by electromechanical morcellation. J Minim Invasive Gynecol. 2016;23(1):12–13. doi: 10.1016/j.jmig.2015.08.002.
   PubMedGoogle Scholar
• Moawad NS, Palin H. Hysteroscopic myomectomy. Obstet Gynecol Clin North Am. 2022;49(2):329–353. doi: 10.1016/j.ogc.2022.02.012.
   PubMedGoogle Scholar
• Loddo A, Djokovic D, Drizi A, et al. Hysteroscopic myomectomy: the guidelines of the International Society for Gynecologic Endoscopy (ISGE). Eur J Obstet Gynecol Reprod Biol. 2022;268:121–128. doi: 10.1016/j.ejogrb.2021.11.434.
   PubMed Web of Science ®Google Scholar
• Dumitraşcu MC, Nenciu C-G, Nenciu A-E, et al. Laparoscopic myomectomy – the importance of surgical techniques. Front Med. 2023;10:1251421. doi: 10.3389/fmed.2023.1158264.
   Google Scholar
• Ricci S, Stone RL, Fader AN. Uterine LMS: epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol. 2017;145(1):208–216. doi: 10.1016/j.ygyno.2017.02.019.
   PubMed Web of Science ®Google Scholar
• Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication. Published 2014; [cited 2020 Aug 5]. Available from: https://wayback.archive-it. Org/7993/20170404182209/https:/www.fda.gov/MedicalDevices/ Safety/AlertsandNotices/ucm424443.htm.
   Google Scholar
• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2018;125(3):354–364. doi: 10.1111/1471-0528.14689.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang WW, He M, et al. Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases. Int J Hyperthermia. 2018;35(1):56–61. doi: 10.1080/02656736.2018.1473894.
   PubMed Web of Science ®Google Scholar
• Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG. 2020;127(11):1422–1428. doi: 10.1111/1471-0528.16262.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wu X, Zhu X, et al. MRI features and clinical outcomes of unexpected uterine sarcoma in patients who underwent high-intensity focused ultrasound ablation for presumed uterine fibroids. Int J Hyperthermia. 2021;38(2):39–45. doi: 10.1080/02656736.2021.1921288.
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Carcangiu ML, Herrington CS, et al. 2014 WHO Classification of Tumours of Female Reproductive Organs.
   Google Scholar
• Lakhman Y, Veeraraghavan H, Chaim J, et al. Differentiation of uterine LMS from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur Radiol. 2017;27(7):2903–2915. doi: 10.1007/s00330-016-4623-9.
   PubMed Web of Science ®Google Scholar
• Smith J, Zawaideh JP, Sahin H, et al. Differentiating uterine sarcoma from leiomyoma: BET1T2ER Check!. Br J Radiol. 2021;0:20201332.
   Google Scholar
• Kaganov H, Ades A, Fraser DS. Preoperative magnetic resonance imaging diagnostic features of uterine LMSs: a systematic review. Int J Technol Assess Health Care. 2018;34(2):172–179. doi: 10.1017/S0266462318000168.
   PubMedGoogle Scholar
• Rio G, Lima M, Gil R, et al. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from LMSs? Abdom Radiol. 2019;44(10):3388–3397. doi: 10.1007/s00261-019-02097-x.
   PubMedGoogle Scholar
• Barral M, Placé V, Dautry R, et al. Magnetic resonance imaging features of uterine sarcoma and mimickers. Abdom Radiol. 2017;42(6):1762–1772. doi: 10.1007/s00261-017-1076-9.
   PubMed Web of Science ®Google Scholar
• Li HM, Liu J, Qiang JW, et al. Diffusion-weighted imaging for differentiating uterine LMS from degenerated leiomyoma. J Comput Assist Tomogr. 2017;41(4):599–606. doi: 10.1097/rct.0000000000000565.
   PubMedGoogle Scholar
• DeMulder D, Ascher SM. Uterine LMS: can MRI differentiate LMS from Benign leiomyoma before treatment? AJR Am J Roentgenol. 2018;211(6):1405–1415. doi: 10.2214/ajr.17.19234.
   PubMed Web of Science ®Google Scholar
• Sun S, Bonaffini PA, Nougaret S, et al. How to differentiate uterine LMS from leiomyoma with imaging. Diagn Interv Imaging. 2019;100(10):619–634. doi: 10.1016/j.diii.2019.07.007.
   PubMedGoogle Scholar
• Bura V, Pintican RM, David RE, et al. MRI findings in-between leiomyoma and LMS: a Rad-Path correlation of degenerated leiomyomas and variants. Br J Radiol. 2021;94(1125):20210283.
   PubMedGoogle Scholar
• Cho HY, Kim K, Kim YB, et al. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics. J Obstet Gynaecol Res. 2016;42(3):313–318. doi: 10.1111/jog.12915.
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180. doi: 10.1016/s1470-2045(14)71116-7.
   PubMed Web of Science ®Google Scholar
• Pan YX, Chen JC, Fang AP, et al. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy. Cancer Commun. 2019;39(1):55. doi: 10.1186/s40880-019-0404-6.
   Google Scholar
• Lv J, Liu YY, Jia YT, et al. A nomogram model for predicting prognosis of obstructive colorectal cancer. World J Surg Oncol. 2021;19(1):337. doi: 10.1186/s12957-021-02445-6.
   PubMed Web of Science ®Google Scholar
• Liu H, Li Z, Zhang Q, et al. Multi‑institutional development and validation of a nomogram to predict prognosis of early-onset gastric cancer patients. Front Immunol. 2022;13:1007176. doi: 10.3389/fimmu.2022.1007176.
   PubMedGoogle Scholar
• Hindman N, Kang S, Fournier L, et al. MRI evaluation of uterine masses for risk of LMS: a consensus statement. Radiology. 2023;306(2):e211658. doi: 10.1148/radiol.211658.
   PubMedGoogle Scholar
• Takamizawa S, Minakami H, Usui R, et al. Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecol Obstet Invest. 1999;48(3):193–196. doi: 10.1159/000010172.
   PubMed Web of Science ®Google Scholar
• George S, Barysauskas C, Serrano C, et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine LMS. Cancer. 2014;120(20):3154–3158. doi: 10.1002/cncr.28844.
   PubMed Web of Science ®Google Scholar
• Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine LMS: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008;112(4):820–830. doi: 10.1002/cncr.23245.
   PubMed Web of Science ®Google Scholar
• Byar KL, Fredericks T, Uterine LMS. Uterine Leiomyosarcoma. J Adv Pract Oncol. 2022;13(1):70–76. doi: 10.6004/jadpro.2022.13.1.6.
   PubMedGoogle Scholar
• Chan JK, Kawar NM, Shin JY, et al. ESS: a population-based analysis. Br J Cancer. 2008;99(8):1210–1215. doi: 10.1038/sj.bjc.6604527.
   PubMedGoogle Scholar